lansoprazole has been researched along with Short Bowel Syndrome in 1 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Short Bowel Syndrome: A malabsorption syndrome resulting from extensive operative resection of the SMALL INTESTINE, the absorptive region of the GASTROINTESTINAL TRACT.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoshioka, M | 1 |
| Watanabe, T | 1 |
| Iida, M | 1 |
| Nakagawa, Y | 1 |
| Uchinami, H | 1 |
| Watanabe, G | 1 |
| Abe, Y | 1 |
| Yagi, F | 1 |
| Yokoyama, N | 1 |
| Yamamoto, Y | 1 |
1 other study available for lansoprazole and Short Bowel Syndrome
| Article | Year |
|---|---|
Effect of Lansoprazole on the Control of the Intragastric pH in a Patient with Short Bowel Syndrome.
Topics: Adult; Anti-Ulcer Agents; Gastric Acid; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Qual | 2019 |